NuVasive, Inc. NUVA
Set alert
39.75 0.00 0.00%
At close · Aug 31
39.51 Day range 40.96
52-week range unavailable
- Open
- 40.62
- Prev close
- 39.75
- Mkt cap
- 2.08B
- Vol
- 30.59M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 39.51
- High
- 40.96
- Forward P/E
- 16.86
- Beta
- 1.07
- Short ratio
- 10.39
- Inst. own
- 112.85%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 2, 2023
- 50-d avg
- 40.46
- 200-d avg
- 41.49
- 1y target
- 48.73
Analyst view
Consensus: hold
Hold
Price target (mean) 48.73 +22.6% upside
Now 39.75
- Target (low)
- 40.00
- Target (mean)
- 48.73
- Target (high)
- 58.00
Ratings (0m) 18 13 buy · 4 hold · 1 sell
- Strong buy6
- Buy7
- Hold4
- Sell1
- Strong sell0
Recommendation trend
- This month 18
- 1 month ago 16
- 2 months ago 17
- 3 months ago 19
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.55 | 0.48 – 0.60 | 0.47 | +17.0% | 322.38M | +3.8% | 14 |
| Next quarter | 0.54 | 0.46 – 0.65 | 0.54 | 0.0% | 318.10M | +7.7% | 14 |
| Current year | 2.18 | 1.97 – 2.33 | 1.98 | +10.1% | 1.29B | +7.0% | 14 |
| Next year | 2.56 | 2.12 – 2.84 | 2.18 | +17.4% | 1.37B | +6.6% | 14 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 31, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 15, 2023 | RBC Capital | Reiterated | Outperform | Outperform |
| May 12, 2023 | Barclays | Maintained | Overweight | Overweight |
| May 11, 2023 | RBC Capital | Reiterated | Outperform | Outperform |
| May 11, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Feb 23, 2023 | JP Morgan | Maintained | — | Neutral |
| Feb 23, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Feb 10, 2023 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Feb 10, 2023 | Truist Securities | Downgrade | Buy | Hold |
| Feb 10, 2023 | Citigroup | Downgrade | Buy | Neutral |
| Feb 9, 2023 | Piper Sandler | Downgrade | Overweight | Neutral |
| Jan 31, 2023 | Truist Securities | Maintained | — | Buy |
| Jan 6, 2023 | Needham | Downgrade | Buy | Hold |
| Nov 10, 2022 | RBC Capital | Maintained | — | Outperform |
| Nov 10, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Nov 10, 2022 | Wells Fargo | Maintained | — | Overweight |
| Nov 10, 2022 | Piper Sandler | Maintained | — | Overweight |
| Nov 10, 2022 | Needham | Maintained | — | Buy |
| Oct 18, 2022 | Barclays | Initiated | — | Overweight |
| Oct 12, 2022 | Jefferies | Initiated | — | Hold |
| Oct 7, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Oct 7, 2022 | Truist Securities | Maintained | — | Buy |
| Oct 7, 2022 | Baird | Maintained | — | Neutral |
| Sep 30, 2022 | Needham | Maintained | — | Buy |
| Aug 4, 2022 | Piper Sandler | Maintained | — | Overweight |
| Jul 15, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| May 6, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| May 5, 2022 | Wells Fargo | Maintained | — | Overweight |
| May 5, 2022 | Needham | Maintained | — | Buy |
| Mar 28, 2022 | Wells Fargo | Initiated | — | Overweight |